{{Rsnum
|rsid=603424
|Gene=PKD2L1
|Chromosome=10
|position=102075479
|Orientation=plus
|GMAF=0.2815
|Gene_s=PKD2L1
|Assembly=GRCh37.p5
|GenomeBuild=37.3
|dbSNPBuild=135
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}
{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 8.0 | 23.9 | 68.1
| HCB | 1.5 | 16.1 | 82.5
| JPT | 0.9 | 4.4 | 94.7
| YRI | 64.6 | 29.3 | 6.1
| ASW | 35.1 | 52.6 | 12.3
| CHB | 1.5 | 16.1 | 82.5
| CHD | 0.0 | 13.8 | 86.2
| GIH | 22.8 | 55.4 | 21.8
| LWK | 55.5 | 35.5 | 9.1
| MEX | 3.4 | 27.6 | 69.0
| MKK | 50.6 | 40.4 | 9.0
| TSI | 6.9 | 44.1 | 49.0
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=21886157
|Trait=None
|Title=Human metabolic individuality in biomedical and pharmaceutical research.
|RiskAllele=A
|Pval=3E-57
|OR=0.1240
|ORtxt=None
|OA=1
}}
{{PMID Auto GWAS
|PMID=22359512
|Trait=None
|Title=Genome-wide association study identifies novel loci associated with circulating phospho- and sphingolipid concentrations.
|RiskAllele=
|Pval=6E-14
|OR=1.4000
|ORtxt=None
|OA=1
}}

{{PMID Auto GWAS
  |PMID=23362303
  |Trait=Palmitic acid (16:0) plasma levels
  |Title=Genome-wide association study identifies novel loci associated with concentrations of four plasma phospholipid fatty acids in the de novo lipogenesis pathway: results from the Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) consortium.
  |RiskAllele=A
  |Pval=2E-7
  |OR=.19
  |ORtxt=unit increase
  |OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}
{{on chip | NatGeo2}}